Home > Resources > Infographics > 2016 global life sciences sector outlook

2016 global life sciences sector outlook

July 19, 2016

The pressure to reduce costs, increase efficiency, and provide value are starting to be seen global health care spend to grow at only at 4.3% annually to 2019 % of GDP spent on health care globally is expected to decrease to 10.1% by 2019 Economic uncertainty, Eurozone crisis, and currency devaluation are expected to impact spending. India to lead the way at 16.1% growth by 2019.

Spotlight

PENDOPHARM

With a strategic focus on growth, PENDOPHARM is actively engaged in licensing, partnering, developing and marketing specialty prescription medicines as well as consumer healthcare products.

Other Infographics

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.